ALBERTDAVD vs SMSPHARMA: Stock Comparison

ALBERT DAVID vs SMS PHARMACEUTICALSUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

SMS PHARMACEUTICALS is the larger company by market capitalisation. ALBERT DAVID shows a lower P/E, a higher dividend yield and faster revenue growth, while SMS PHARMACEUTICALS shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALBERTDAVD leads 7; SMSPHARMA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALBERTDAVDSMSPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹493 Cr
₹3,684 Cr
P/E RatioALBERTDAVD has the lower reading
20.47x
34.01x
P/B RatioALBERTDAVD has the lower reading
1.18x
4.45x
EPSALBERTDAVD has the higher reading
₹56.07
₹2.23
Book ValueContext only
₹686.04
₹83.91
Dividend YieldALBERTDAVD has the higher reading
0.58%
0.11%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SMSPHARMA is the larger company
₹3,684 Cr vs ₹493 Cr
P/E Ratio
ALBERTDAVD has a lower P/E
20.47x vs 34.01x
P/B Ratio
ALBERTDAVD has a lower P/B
1.18x vs 4.45x
EPS
ALBERTDAVD has higher earnings per share
₹56.07 vs ₹2.23
Dividend Yield
ALBERTDAVD has a higher dividend yield
0.58% vs 0.11%
Revenue Growth (TTM YoY)
ALBERTDAVD has faster revenue growth
14.6% vs -4.1%
EPS Growth (TTM YoY)
SMSPHARMA has faster EPS growth
49.2% vs 0%
Qtr Sales Growth
SMSPHARMA has stronger quarterly sales growth
0% vs -69.62%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDSMSPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDSMSPHARMA
Live Price₹860.25₹392.5
Day Change-1.14%4.9%
Volume3,3394.73 L
52-Week High₹931.85₹447.8
52-Week Low₹579.9₹231
Distance from 52W High-7.68%-12.35%

Valuation

MetricALBERTDAVDSMSPHARMA
Market Cap₹493 Cr₹3,684 Cr
P/E Ratio20.47x34.01x
P/B Ratio1.18x4.45x
EPS₹56.07₹2.23
Book Value₹686.04₹83.91
Dividend Yield0.58%0.11%

Growth

MetricALBERTDAVDSMSPHARMA
Revenue Growth (TTM YoY)14.6%-4.1%
EPS Growth (TTM YoY)0%49.2%
Qtr Sales Growth-69.62%0%
Qtr Profit Growth2,240.75%-1.06%

Profitability & Leverage

MetricALBERTDAVDSMSPHARMA
ROE-0.38%12.98%
ROCE-2.14%9.79%
Net Margin-0.45%11.5%
Operating Margin0.95%15.75%
Debt to Equity0.07x0.46x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALBERTDAVDSMSPHARMA
Promoter Holding62.24%68.07%
FII Holding0.57% 0.01 pp0.65% 0.34 pp
DII Holding1.64% 0.02 pp2.83% 0.19 pp
Public Holding35.56% 0.04 pp28.45% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALBERT DAVID and SMS PHARMACEUTICALS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.